Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 3 2Phase 4 1

Status

Not yet recruiting 1Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Classical hematology 1

Conditions

Venous Thrombosis 2Neoplasms 2Venous Thromboembolism 1Pulmonary Embolism 1

Interventions

apixaban 5Dalteparin 5edoxaban 2bemiparin 2abelacimab 2Tinzaparin 2Nadroparin 2MAA868 2Heparin, Low-Molecular-Weight 2Enoxaparin 2reviparin 1isoquercitrin 1certoparin 1atezolizumab 1acarboxyprothrombin 1Warfarin 1Rivaroxaban 1Phenprocoumon 1Intermittent Pneumatic Compression Devices 1Fondaparinux 1Dabigatran 1Bevacizumab 1Acenocoumarol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Venous Thrombosis × edoxaban × Clear all
NCT06149533 2023-11-29

Thrombosis

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Phase 3 Not yet recruiting
366 enrolled

Neoplasms, Venous Thrombosis

NCT02073682 2019-03-06

Cancer Venous Thromboembolism (VTE)

Daiichi Sankyo

Phase 3 Completed
1,046 enrolled 24 charts
Classical hematology

Neoplasms, Pulmonary Embolism, Venous Thrombosis, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡